ClinVar Miner

Submissions for variant NM_001352514.2(HLCS):c.1151T>C (p.Leu384Pro)

dbSNP: rs119103227
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000001984 SCV000485745 likely pathogenic Holocarboxylase synthetase deficiency 2016-07-22 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000001984 SCV004028689 pathogenic Holocarboxylase synthetase deficiency 2023-07-26 criteria provided, single submitter clinical testing Variant summary: HLCS c.710T>C (p.Leu237Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251258 control chromosomes in the gnomAD database, and found at a frequency of 0.0004 in 2420 control chromosomes in the Japanese population (HGVD-Kyoto). c.710T>C has been reported in the literature in homozygous and compound heterozygous individuals affected with Holocarboxylase Synthetase Deficiency, often with neonatal onset (e.g. Aoki_1995, Yang_2001). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal Holocarboxylase Synthetase (HCS) activity in homozygous patient fibroblast cells (e.g. Aoki_1995). The following publications have been ascertained in the context of this evaluation (PMID: 8541348, 11735028). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Baylor Genetics RCV000001984 SCV004199860 pathogenic Holocarboxylase synthetase deficiency 2023-03-21 criteria provided, single submitter clinical testing
OMIM RCV000001984 SCV000022142 pathogenic Holocarboxylase synthetase deficiency 1994-10-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.